Integrated Oncology (United States)

Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer – results from the phase II DETECT IVb trial

Abstract Background Eribulin is a non-taxane microtubule inhibitor that showed survival benefits for pretreated metastatic breast cancer (MBC) patients. Circulating tumor cells (CTCs) are a prognostic marker, but their role in predicting response to specific MBC treatments is les...

Describing the emotional change experienced by patients with chronic somatic diseases who took part in a supportive program with complementary therapies: a qualitative study

Quantitative studies have suggested that complementary therapies (including mind-body and art therapies) are relevant to support patients with chronic somatic diseases. The “Health Promotion Education” department of Nantes University Hospital created in 2012 an association entitl...

Exploring vertical genomic heterogeneity and chemotherapy response using targeted genomic sequencing in muscle-invasive bladder cancer

We performed a targeted genomic sequence of muscle-invasive bladder cancer (MIBC) tissues to investigate vertical intratumoral heterogeneity, invasion processes, and potential biomarkers of platinum-based neoadjuvant chemotherapy (NAC) efficacy in MIBC. Mutations in key genes tho...